These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31610604)

  • 1. [Caffeine, the most frequently consumed psychostimulant: a narrative review article].
    Gahr M
    Fortschr Neurol Psychiatr; 2020 May; 88(5):318-330. PubMed ID: 31610604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology.
    Donovan JL; DeVane CL
    Psychopharmacol Bull; 2001; 35(3):30-48. PubMed ID: 12397877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine eliminates psychomotor vigilance deficits from sleep inertia.
    Van Dongen HP; Price NJ; Mullington JM; Szuba MP; Kapoor SC; Dinges DF
    Sleep; 2001 Nov; 24(7):813-9. PubMed ID: 11683484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine and the dopaminergic system.
    Cauli O; Morelli M
    Behav Pharmacol; 2005 Mar; 16(2):63-77. PubMed ID: 15767841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine, fatigue, and cognition.
    Lorist MM; Tops M
    Brain Cogn; 2003 Oct; 53(1):82-94. PubMed ID: 14572506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns.
    Aranda JV; Beharry KD
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101183. PubMed ID: 33293242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine, exercise and the brain.
    Meeusen R; Roelands B; Spriet LL
    Nestle Nutr Inst Workshop Ser; 2013; 76():1-12. PubMed ID: 23899750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of theobromine and caffeine on mood and vigilance.
    Judelson DA; Preston AG; Miller DL; Muñoz CX; Kellogg MD; Lieberman HR
    J Clin Psychopharmacol; 2013 Aug; 33(4):499-506. PubMed ID: 23764688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.
    Ferre S; Ciruela F; Borycz J; Solinas M; Quarta D; Antoniou K; Quiroz C; Justinova Z; Lluis C; Franco R; Goldberg SR
    Front Biosci; 2008 Jan; 13():2391-9. PubMed ID: 17981720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically significant pharmacokinetic interactions between dietary caffeine and medications.
    Carrillo JA; Benitez J
    Clin Pharmacokinet; 2000 Aug; 39(2):127-53. PubMed ID: 10976659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptors.
    Higgins GA; Grzelak ME; Pond AJ; Cohen-Williams ME; Hodgson RA; Varty GB
    Behav Brain Res; 2007 Dec; 185(1):32-42. PubMed ID: 17707919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure.
    Quarta D; Ferré S; Solinas M; You ZB; Hockemeyer J; Popoli P; Goldberg SR
    J Neurochem; 2004 Mar; 88(5):1151-8. PubMed ID: 15009670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Opportunities for Caffeine and A2A Receptor Antagonists in Retinal Diseases.
    Boia R; Ambrósio AF; Santiago AR
    Ophthalmic Res; 2016; 55(4):212-8. PubMed ID: 26959995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craving espresso: the dialetics in classifying caffeine as an abuse drug.
    Dos Santos MKF; Gavioli EC; Rosa LS; de Paula Soares-Rachetti V; Lobão-Soares B
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1301-1318. PubMed ID: 30338342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of blood pressure measurement related to caffeine consumption.
    Mort JR; Kruse HR
    Ann Pharmacother; 2008 Jan; 42(1):105-10. PubMed ID: 18094346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep restriction.
    Rogers PJ; Heatherley SV; Hayward RC; Seers HE; Hill J; Kane M
    Psychopharmacology (Berl); 2005 Jun; 179(4):742-52. PubMed ID: 15887055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects.
    Nehlig A; Daval JL; Debry G
    Brain Res Brain Res Rev; 1992; 17(2):139-70. PubMed ID: 1356551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Janus face of caffeine.
    Porciúncula LO; Sallaberry C; Mioranzza S; Botton PH; Rosemberg DB
    Neurochem Int; 2013 Nov; 63(6):594-609. PubMed ID: 24055856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of caffeine's effects on cognitive, physical and occupational performance.
    McLellan TM; Caldwell JA; Lieberman HR
    Neurosci Biobehav Rev; 2016 Dec; 71():294-312. PubMed ID: 27612937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine citrate: when and for how long. A literature review.
    Picone S; Bedetta M; Paolillo P
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():11-4. PubMed ID: 23016611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.